Unibest
← Back to patent-cliff list

CAS 960303-94-0

N-{5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenyl}formamide

Codes: Formoterol Fumarate-013

Application context (from source-drug indications)

AsthmaBudesonide/Formoterol fumarate/Glycopyrronium BromideChronic obstructive pulmonary diseaseBudesonide/Formoterol fumarate/Glycopyrronium BromideChronic obstructive pulmonary diseaseFormoterol Fumarate/GlycopyrrolateChronic obstructive pulmonary diseaseFormoterol FumarateEmphysemaFormoterol FumarateAsthmaFormoterol FumarateBronchitisFormoterol FumarateDiabetic nephropathyFormoterol FumarateBronchospasmFormoterol Fumarate

Source drugs (routes using this intermediate)

DrugTierExpiry
Budesonide/Formoterol fumarate/Glycopyrronium BromideTier B — Position early-
Formoterol Fumarate/GlycopyrrolateTier C — Watch / trade-
Formoterol FumarateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Budesonide/Formoterol fumarate/Glycopyrronium BromideOptimised routesteps: 1total yield: /
N-{5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenyl}formamide→1-(4-Methoxyphenyl)-2-propanone→1,2-Ethylenedicarboxylic acid
Formoterol Fumarate/GlycopyrrolateOptimised routesteps: 1total yield: /
N-{5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenyl}formamide→1-(4-Methoxyphenyl)-2-propanone→1,2-Ethylenedicarboxylic acid
Formoterol FumarateOptimised routesteps: 1total yield: /
N-{5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenyl}formamide→1-(4-Methoxyphenyl)-2-propanone→1,2-Ethylenedicarboxylic acid

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.